Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9PM6

Cryo-EM structure of modified Zika virus E protein dimer complexed with a neutralizing antibody OZ-D4 Fab

This is a non-PDB format compatible entry.
Summary for 9PM6
Entry DOI10.2210/pdb9pm6/pdb
EMDB information71728
DescriptorEnvelope protein E, OZ-D4 Heavy chain, OZ-D4 Light chain (3 entities in total)
Functional Keywordsneutralizing antibody, viral protein, viral protein-immune system complex
Biological sourceZika virus
More
Total number of polymer chains6
Total formula weight188366.51
Authors
Galkin, A.,Pozharski, E.,Li, Y. (deposition date: 2025-07-16, release date: 2026-01-21)
Primary citationWang, Y.,Galkin, A.,Shang, X.,Marin, A.,Jin, S.,Ye, T.J.,Bale, S.,Chiang, C.I.,Chowdhury, A.,Chenine, A.L.,Turonis, A.,Greenhouse, J.,Stone, R.,Wear, J.,Kar, S.,Andersen, H.,Huang, Y.S.,Vanlandingham, D.L.,Higgs, S.,Lapidus, R.G.,Fuerst, T.,Weber, D.J.,Wyatt, R.T.,Iffland, C.,Pierson, T.C.,Andrianov, A.K.,Pozharski, E.,Li, Y.
Rational design of flavivirus E protein vaccine optimizes immunogenicity and mitigates antibody dependent enhancement risk.
Nat Commun, 16:11558-11558, 2025
Cited by
PubMed Abstract: Flaviviruses are a family of related viruses that cause substantial global morbidity and mortality. Vaccination against one flavivirus can sometimes exacerbate disease caused by related viruses through antibody-dependent enhancement (ADE) or interfere with the efficacy of subsequent vaccines. To address this challenge, we develop a vaccine strategy by introducing G5C/G102C mutations into the flavivirus envelope (E) glycoprotein. These mutations promote E dimerization through the formation of an inter-chain disulfide bond that conceals the immunodominant and ADE-prone fusion loop epitope (FLE). We validate this design on E proteins from multiple flaviviruses through biochemical, antigenic, and structural analyses. The resulting vaccine candidate, CC_FLE sE, derived from the Zika virus (ZIKV) and formulated with an advanced supramolecular adjuvant, provides significant protection in female mice challenged with ZIKV and prevents ADE caused by a related flavivirus, Dengue virus. In genetically modified mice expressing diverse human immunoglobulin loci, ZIKV CC_FLE sE induces robust neutralizing antibody responses targeting key ZIKV E protein epitopes, including the E-dimer-dependent epitope (EDE), indicating that ZIKV CC_FLE sE can elicit protective antibody responses within the human naïve B cell repertoire. Therefore, CC_FLE sE represents a promising strategy for developing flavivirus vaccines that minimize ADE risk while maintaining high protective efficacy.
PubMed: 41429771
DOI: 10.1038/s41467-025-67447-4
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.45 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon